![Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrendo.2009.151/MediaObjects/41574_2009_Article_BFnrendo2009151_Fig1_HTML.jpg)
Myopathy with statin–fibrate combination therapy: clinical considerations | Nature Reviews Endocrinology
![A comprehensive schematic diagram of the proposed mechanisms of statin... | Download Scientific Diagram A comprehensive schematic diagram of the proposed mechanisms of statin... | Download Scientific Diagram](https://www.researchgate.net/profile/Mark-Tarnopolsky/publication/11746030/figure/fig1/AS:667203011624974@1536085002563/A-comprehensive-schematic-diagram-of-the-proposed-mechanisms-of-statin-myopathy.png)
A comprehensive schematic diagram of the proposed mechanisms of statin... | Download Scientific Diagram
![Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease - Kidney International Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease - Kidney International](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2043442387/2056059558/gr1.jpg)
Effects of HMG-CoA reductase inhibitors (statins) on progression of kidney disease - Kidney International
![Figure 2 from Drug-induced rhabdomyolysis: from systems pharmacology analysis to biochemical flux. | Semantic Scholar Figure 2 from Drug-induced rhabdomyolysis: from systems pharmacology analysis to biochemical flux. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/8acb5b55ef4f2b92b57962f985b1244ba0951a5b/3-Figure2-1.png)
Figure 2 from Drug-induced rhabdomyolysis: from systems pharmacology analysis to biochemical flux. | Semantic Scholar
![JCM | Free Full-Text | Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components | HTML JCM | Free Full-Text | Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components | HTML](https://www.mdpi.com/jcm/jcm-09-00022/article_deploy/html/images/jcm-09-00022-g001.png)
JCM | Free Full-Text | Statin-Related Myotoxicity: A Comprehensive Review of Pharmacokinetic, Pharmacogenomic and Muscle Components | HTML
Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge
![The role of mitochondria in statin‐induced myopathy - Apostolopoulou - 2015 - European Journal of Clinical Investigation - Wiley Online Library The role of mitochondria in statin‐induced myopathy - Apostolopoulou - 2015 - European Journal of Clinical Investigation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/547bf7df-190f-419f-985c-a0891bb0a5a7/eci12461-fig-0001-m.jpg)
The role of mitochondria in statin‐induced myopathy - Apostolopoulou - 2015 - European Journal of Clinical Investigation - Wiley Online Library
![Acute renal failure secondary to rhabdomyolysis in a patient receiving treatment with ticagrelor and atorvastatin | Nefrología Acute renal failure secondary to rhabdomyolysis in a patient receiving treatment with ticagrelor and atorvastatin | Nefrología](https://multimedia.elsevier.es/PublicationsMultimediaV1/item/multimedia/S2013251419301178:gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w92lL8PRnKGMnsiVXV6EVJ5QRkjJZIKj2umwUyY+cL6K8cyMCoG0zLrx/ORKa7YTjKW8rjIzQFQzLroHR1a8SbHaeYWRvApr4j1rl7dmUJz7bQv46c+Zb4VKNHvvku1YYDJgQvasQrIB7C9MBd9S6tPdPYuc5hk/3D4sA6WegVYX1dL55N9N0DT9g06qg7EJuj4oruFkweBNI2qCnFnMivG20grkiOMM6XwEON2tyild92jHPYlLAeZ1WArGxD8eykKtAvxYnyMV8+2sLOuAZ2XPLB19gweiJ6rEcPrqLdAKa)
Acute renal failure secondary to rhabdomyolysis in a patient receiving treatment with ticagrelor and atorvastatin | Nefrología
![Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions | Pharmacogenomics Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions | Pharmacogenomics](https://www.futuremedicine.com/cms/10.2217/pgs.12.11/asset/images/medium/figure1.gif)
Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions | Pharmacogenomics
![Alan Watson on Twitter: "All statins cause "muscle wasting" rhabdomyolysis. In the last 7 yrs, there have been 1,000 deaths from rhabdomyolysis - often listed as "renal failure" not as a statin " Alan Watson on Twitter: "All statins cause "muscle wasting" rhabdomyolysis. In the last 7 yrs, there have been 1,000 deaths from rhabdomyolysis - often listed as "renal failure" not as a statin "](https://pbs.twimg.com/media/DuUKQ_qWsAA1QoK.jpg)